Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445471
Status:
TERMINATED
Last Update Posted:
2014-12-25
First Post:
2007-03-08
Brief Title:
A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment
Sponsor:
Rabin Medical Center
Organization:
Rabin Medical Center
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Mifne began treating younger patients who could not be diagnosed with the ADOS used in the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current study aims at comparing outcomes achieved using the Mifne approach of treating autistic children with results obtained when routine standard treatment is used A prospective comparative study will be performed comparing the results of 12 children treated at Mifne with 12 children treated with treatment as usual A child and adolescent psychiatrist using the Autism Diagnostic Interview-Revised ADI-R and the Autism Diagnostic Observation Schedule-Generic ADOS-G will make the diagnostic assessment and a developmental psychologist will make the developmental and psychological assessments using the Vineland Adaptive Behavior Scales-Revised and the Bayley Scales of Infant Development BSID II before the child enters the study Each child will be reassessed following completion of the Mifne intervention at three and at six months after commencement of treatment The control child will also be reassessed at three and at six months after commencement of a therapeutic intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None